Repeat CRS/HIPEC Improves Survival for Peritoneal Mesothelioma
One of the country’s top peritoneal mesothelioma surgeons has just published a study that may be good news for patients…
-
-
Biomarkers | Chemotherapy | Diagnosis | New Techniques | Prognosis | Treatments | Updates
Enzyme Makes Mesothelioma More Aggressive, Less Responsive to Treatment
There’s new evidence that a glycoprotein produced on the surface of some mesothelioma cells could have a major impact on… -
Asia | Chemotherapy | International | Prognosis | Treatments | Updates
Albumin Levels May Help Predict Mesothelioma Survival
People with the lowest levels of the blood protein albumin are less likely to live beyond a year with malignant… -
Mesothelioma Cells Respond Better to Chemotherapy Drug When Pretreated with Two Compounds
There’s new evidence that a transplant anti-rejection drug and a chemical compound similar to curcumin may both increase the mesothelioma-fighting… -
Kidney Risk May be Unavoidable with Top Mesothelioma Drug
Italian scientists studying the popular mesothelioma chemotherapy drug pemetrexed (Alimta) have some sobering news for patients: Kidney damage remains a… -
Chemotherapy | Genetics | Prognosis | Research | Treatments | Updates
Genetic Variables Impact Mesothelioma Treatment Outcomes
Researchers in Slovenia say they may have found a method for determining which mesothelioma patients are most likely to respond… -
New Mesothelioma Treatment Boosts Chemotherapy Response
An important new study from one of the country’s top mesothelioma research labs has found a way to significantly boost… -
Chemotherapy | New Studies | Research | Treatments | Updates
Fluid Drainage With Chemotherapy May Be Unneeded
Mesothelioma patients undergoing chemotherapy treatment with pemetrexed (Alimta) may be able to avoid one of the more uncomfortable parts of… -
Chemotherapy | New Studies | Research | Treatments | Updates
Overall Survival “Significantly Higher” After Second-Line Chemotherapy
Researchers in a country especially prone to mesothelioma say second-line chemotherapy with a drug called gemcitabine can significantly improve survival.… -
Combination Treatment Fights Mesothelioma “Synergistically”
Cancer researchers in Italy are working on a way to use the body’s own cancer-fighting tools to help boost the…
